These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 16135585

  • 1. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [Abstract] [Full Text] [Related]

  • 2. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [Abstract] [Full Text] [Related]

  • 3. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [Abstract] [Full Text] [Related]

  • 4. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
    Kang WD, Choi HS, Kim SM.
    Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
    [Abstract] [Full Text] [Related]

  • 5. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [Abstract] [Full Text] [Related]

  • 6. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG.
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [Abstract] [Full Text] [Related]

  • 7. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS.
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [Abstract] [Full Text] [Related]

  • 8. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 9. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2006 Mar; 107(3):743. PubMed ID: 16507954
    [No Abstract] [Full Text] [Related]

  • 10. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 11. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 12. Current management of gestational trophoblastic diseases.
    Berkowitz RS, Goldstein DP.
    Gynecol Oncol; 2009 Mar; 112(3):654-62. PubMed ID: 18851873
    [Abstract] [Full Text] [Related]

  • 13. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
    Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, Mitsuhashi A, Matsui H, Shozu M.
    Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
    [Abstract] [Full Text] [Related]

  • 16. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
    Hemida RA, Toson E, Van Doorn HC.
    J Exp Ther Oncol; 2011 May; 9(3):217-20. PubMed ID: 22070053
    [Abstract] [Full Text] [Related]

  • 17. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB, Granai CO, Ball HG, Curry SL.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [Abstract] [Full Text] [Related]

  • 18. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 19. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.